Effect of Sage Extract Supplementation on Cognitive Function in Middle-Aged Men and Women
ESM Technologies, LLC · with Exercise & Sport Nutrition Lab, Texas A&M University · NCT07757529
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40–60 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 64
- US sites recruiting
- 1
- Study start
- February 15, 2026
- Record last updated
- August 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Sage (Salvia officinalis) has been reported to have antioxidant, anti-inflammatory, and neuroprotective properties. Several studies indicate that sage supplementation can improve cognitive function. However, more research is needed. The purpose of this study is to examine how sage supplementation affects cognitive function and reaction times in middle-aged men and women.
Being studied: SageXtra; Placebo
Conditions: Cognitive Ability, General
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- BMI 18.5-34.9 (inclusive) with a goal of being \< 30 on average
- Subject agrees to maintain their existing dietary patterns throughout the study period.
- Subject agrees to refrain from alcohol, caffeine, and strenuous exercise for 24 hours before each test day.
- Subject is willing and able to comply with the study protocol.
- Has given voluntary, written, informed consent to participate in the study.
Exclusion Criteria
- Individuals with a personal history of a psychiatric disorder.
- Individuals who are determined to have liver, renal, cardiovascular, or other metabolic disease.
- Current or recent (\< 4 weeks) use of any dietary supplements (e.g., choline, lecithin, ginseng, ginkgo biloba, ashwagandha, Bacopa Monnieri, Paullina cupana, Rhodiola rosea, L-theanine, omega-3 fats, Prevagen, etc.), or currently prescribed medications (e.g., Adderall, Mydayis, Ritalin, Concerta, Mythylin, Provigil, Namenda), that may affect cognitive function (focus, concentration, memory, reaction time, energy, etc.).
- Alcohol consumption (>2 standard alcoholic drinks/day or >10 drinks/week) or drug abuse/dependence (including regular marijuana or THC use).
- Currently a smoker.
- Allergy or sensitivity to study product ingredients.
- Individuals who are cognitively impaired and/or who are unable to give informed consent.
- Any other condition which, in the PI's opinion, may adversely affect the subject's ability to complete the study, its measurements, or pose a significant risk to the subject.
Recruiting US locations
Exercise & Sport Nutrition Lab - Texas A&M University
College Station, TX 77843
Site contact: Richard B. Kreider, Ph.D. · (979) 458-1498 · rbkreider@tamu.edu
Study contacts (from the official record)
- Richard B. Kreider, Ph.D. · (979) 458-1498 · rbkreider@tamu.edu
- Christopher Rasmussen, M.S. · (979) 458-1498 · crasmussen@tamu.edu
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75